DRKS00021226尚未招募不适用
PROTEGO: PRospective Observational cohort Trial Evaluating correlation of clinical findings, symptoms and disease development of German in- or Outpatients infected with SARS-CoV-2 - a CHIR-Net Student-Initiated German Medical Audit trial COVID-19 study (CHIR-Net SIGMA study group) - PROTEGO
niversitätsklinikum Heidelberg0 个研究点目标入组 500 人开始时间: 2020年5月4日最近更新:
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 500
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 one（—）
- 性别
- All
入选标准
- •1.Age = 18 years
- •2.SARS-CoV-2 infection confirmed in molecular testing
- •3.Ability of the patient to understand the character and individual consequences of the study
- •4.Informed consent
排除标准
- •Patients with a legal guardian
研究者
相似试验
终止
不适用
An observational research study to examine the usefulness of a test called FoundationOne (Registered Trademark) in providing some recommended treatment options for patients with cancer where the location of the cancer cannot yet be found.ACTRN12616000331437Foundation Medicine, Inc.500
尚未招募
不适用
PROBEL; Prognostics in the Treatment Evaluation of the National System for Veterans' CarePosttraumatische Stressstoornis, Posttraumatic Stress DisorderNL-OMON29049Stichting Centrum '45 partner in ARQ National Psychotrauma Center, Diemen/Oegstgeest, the Netherlands260
招募中
4 期
ong term prospective observational cohort study on the safety and efficacy of abatacept subcutaneus in the daily clinical practice of rheumatoid arthritisInflammatory rheumatic disease10023213NL-OMON39013Jan van Breemen Instituut100
招募中
4 期
ong term prospective observational cohort study of the safety and efficacy of golimumab in the daily clinical practice of rheumatoid arthritis with emphasis on the lipid profileinflammatory rheumatic disease1000381610023213NL-OMON36406Jan van Breemen Instituut200
招募中
4 期
ong term prospective observational cohort study of the safety and efficacy of certolizumab pegol in the daily clinical practice of rheumatoid arthritis with emphasis on the lipid profileinflammatory rheumatic disease1000381610023213NL-OMON36770Jan van Breemen Instituut200